A Thickened Amino-Acid Formula in Infants with Cow’s Milk Allergy Failing to Respond to Protein Hydrolysate Formulas: A Randomized Double-Blind Trial

2014 ◽  
Vol 16 (6) ◽  
pp. 513-522 ◽  
Author(s):  
Christophe Dupont ◽  
Nicolas Kalach ◽  
Pascale Soulaines ◽  
Elena Bradatan ◽  
Alain Lachaux ◽  
...  
Keyword(s):  
Amino Acid ◽  
Protein Hydrolysate ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Double Blind Trial ◽  
Double Blind ◽  
Cow's Milk ◽  
Blind Trial ◽  
Amino Acid Formula

Double Blind Trial of a Fermented Infantile Formula in Cow's Milk Allergy prevention

2008 ◽  
Vol 121 (2) ◽  
pp. S244-S244
Author(s):  
M MORISSET ◽  
P SOULAINES ◽  
C AUBERTJACQUIN ◽  
F CODREANU ◽  
N MAAMRI ◽  
...  
Keyword(s):  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Allergy Prevention ◽  
Milk Allergy ◽  
Double Blind Trial ◽  
Double Blind ◽  
Cow's Milk ◽  
Blind Trial ◽  
Cow's Milk Allergy

Amino acid formula as a new strategy for diagnosing cow’s milk allergy in infants: is it cost-effective?

2016 ◽  
Vol 19 (12) ◽  
pp. 1207-1214 ◽  
Author(s):  
Mauro Batista de Morais ◽  
José Vicente Spolidoro ◽  
Mário César Vieira ◽  
Ary Lopes Cardoso ◽  
Otavio Clark ◽  
...  
Keyword(s):  
Amino Acid ◽  
Cost Effective ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Cow's Milk ◽  
Cow's Milk Allergy ◽  
New Strategy ◽  
Amino Acid Formula

scholarly journals Tolerability of a new amino acid-based formula for children with IgE-mediated cow’s milk allergy

2021 ◽  
Vol 47 (1) ◽  
Author(s):  
Rita Nocerino ◽  
Carmen Di Scala ◽  
Serena Coppola ◽  
Veronica Giglio ◽  
Laura Carucci ◽  
...  
Keyword(s):  
Amino Acid ◽  
Prospective Trial ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Double Blind ◽  
Registration System ◽  
Cow's Milk ◽  
Cow's Milk Allergy ◽  
Study Results

Abstract Background Amino acid-based formula (AAF) is a relevant dietary strategy for paediatric patients affected by cow’s milk allergy (CMA). The present study was designed to evaluate the hypoallergenicity of a new AAF in children with immunoglobulin (Ig)E-mediated CMA. Methods According to the criteria provided by the American Academy of Pediatrics Subcommittee on Nutrition and Allergic Diseases, we designed a prospective trial in CMA children (aged 1–36 months) aimed to demonstrate the hypoallergenicity of the new AAF in 90% of subjects with 95% confidence during the double-blind, placebo-controlled challenge (DBPCFC). A skin prick test (SPT) with the new AAF was also performed. Results Twenty-nine children [all Caucasian, 55.2% male, mean age (±SD) 16.9 ± 5.7 months] were enrolled. The SPT and the DBPCFC with the new AAF were negative in all study subjects. Conclusions The study results support the hypoallergenicity of the new AAF. This formula could be considered an additional dietary option for non-breastfed children affected by CMA. Trial registration The trial was registered in the ClinicalTrials.gov Protocol Registration System (ID number: NCT03909113).

Allergenicity of milk protein hydrolysate formulae in children with cow's milk allergy

1993 ◽  
Vol 152 (9) ◽  
pp. 760-762 ◽  
Author(s):  
V. Ragno ◽  
P. G. Giampietro ◽  
G. Bruno ◽  
L. Businco
Keyword(s):  
Milk Protein ◽  
Protein Hydrolysate ◽  
Cow’S Milk Allergy ◽  
Cow’S Milk ◽  
Milk Allergy ◽  
Cow's Milk ◽  
Cow's Milk Allergy
Sign in / Sign up

Export Citation Format

Share Document